Analysis of the functional role of ADAMTS enzymes in prostate cancer

Analysis of the functional role of ADAMTS enzymes in prostate cancer

Detalles Bibliográficos
Autores principales:	Molokwu, C, Waterman, E, Cross, N, Buttle, D, Hamdy, F, Eaton, C
Formato:	Journal article
Publicado:	2005

Ejemplares similares

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
por: Adeniji, O, et al.
Publicado: (2007)

Regulation of ADAMTS expression in prostate cancer and stromal cells by androgen and TNF
por: Molokwu, C, et al.
Publicado: (2007)

Androgen regulates ADAMTS15 gene expression in prostate cancer cells.
por: Molokwu, C, et al.
Publicado: (2010)

Regulation of ADAMTS15 by dihydrotestosterone in prostate cancer cells and identification of putative androgen response elements
por: Molokwu, C, et al.
Publicado: (2009)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
por: Adeniji, O, et al.
Publicado: (2008)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
por: Adeniji, O, et al.
Publicado: (2007)

Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines
por: Chandrasekharan, S, et al.
Publicado: (2003)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
por: Cross, N, et al.
Publicado: (2005)

Imaging proteolysis in prostate cancer and stromal cells
por: Molokwu, C, et al.
Publicado: (2007)

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells
por: Cross, N, et al.
Publicado: (2008)

Phenotypic variations of TRAIL sensitivity in cloned populations of prostate cancer cells.
por: Cross, N, et al.
Publicado: (2008)

ADAMTS-15 Has a Tumor Suppressor Role in Prostate Cancer
por: Marley J. Binder, et al.
Publicado: (2020-04-01)

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.
por: Mitchell, A, et al.
Publicado: (2013)

EZH2 promotes proliferation and invasiveness of prostate cancer cells.
por: Bryant, R, et al.
Publicado: (2007)

Engineering and expression of ADAMTS-4 and ADAMTS-5, proteolytic enzymes involved in osteoarthritis progression
por: Lauer-Fields, J, et al.
Publicado: (2005)

The polycomb group protein EZH2 is required for transcriptional repression of p21 and MMP7 in prostate cancer cells
por: Bryant, R, et al.
Publicado: (2007)

The antibody MAB8051 directed against osteoprotegerin detects carbonic anhydrase II: implications for association studies with human cancers.
por: Waterman, E, et al.
Publicado: (2007)

The role of osteoprotegerin in breast and prostate cancer
por: Holen, I, et al.
Publicado: (2002)

The Function and Roles of ADAMTS-7 in Inflammatory Diseases
por: Yuying Zhang, et al.
Publicado: (2015-01-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
por: Rehman, I, et al.
Publicado: (2008)

The ADAMTS/Fibrillin Connection: Insights into the Biological Functions of ADAMTS10 and ADAMTS17 and Their Respective Sister Proteases
por: Stylianos Z. Karoulias, et al.
Publicado: (2020-04-01)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
por: Glen, A, et al.
Publicado: (2008)

The role of microRNAs in functional osteomimicry in prostate cancer cells
por: Rao, SR, et al.
Publicado: (2013)

Human bone marrow stromal cells protect prostate and breast cancer cells from TRAIL-induced apoptosis
por: Nyambo, R, et al.
Publicado: (2004)

Functional role of ADAMTS5 in adiposity and metabolic health.
por: Dries Bauters, et al.
Publicado: (2018-01-01)

Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
por: Nyambo, R, et al.
Publicado: (2004)

Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
por: Cross, N, et al.
Publicado: (2008)

Proteolytic activities of human ADAMTS-5: comparative studies with ADAMTS-4.
por: Gendron, C, et al.
Publicado: (2007)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
por: Rehman, I, et al.
Publicado: (2003)

ADAMTS2 and ADAMTS14 can substitute for ADAMTS3 in adults for pro-VEGFC activation and lymphatic homeostasis
por: Laura Dupont, et al.
Publicado: (2022-04-01)

Human bone marrow stromal cell derived IGF signaling enhances PSA production as well as proliferation/survival of androgen sensitive prostate cancer cells in vitro
por: Papageorgiou, M, et al.
Publicado: (2005)

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
por: Cross, N, et al.
Publicado: (2007)

Corrigendum: Data Mining and Expression Analysis of Differential lncRNA ADAMTS9-AS1 in Prostate Cancer
por: Jiahui Wan, et al.
Publicado: (2020-04-01)

ADAMTS expression in colorectal cancer.
por: Serafula Filou, et al.
Publicado: (2015-01-01)

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
por: Holen, I, et al.
Publicado: (2002)

Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity.
por: Fushimi, K, et al.
Publicado: (2008)

ADAMTS6: Emerging roles in cardiovascular, musculoskeletal and cancer biology
por: Timothy J. Mead, et al.
Publicado: (2022-10-01)

ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis
por: Leszczynski Przemyslaw, et al.
Publicado: (2013-03-01)

Qualitative and quantitative PSA mRNA detection in prostate cancer - A useful tool for the clinician?
por: Phillips, J, et al.
Publicado: (2007)

THE ROLE OF ACTIVE MONITORING IN THE MANAGEMENT OF PROSTATE CANCER
por: Hamdy, F
Publicado: (2009)